Baird Medical Investment Holdings Valuation
Is BDMD undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BDMD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate BDMD's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate BDMD's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BDMD?
Other financial metrics that can be useful for relative valuation.
| What is BDMD's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | n/a |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1x |
| Enterprise Value/EBITDA | 2.2x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does BDMD's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 13.2x | ||
VASO Vaso | 10.1x | n/a | US$22.7m |
DXR Daxor | 26.5x | n/a | US$47.4m |
RAYT Rayont | 6.4x | n/a | US$4.6m |
FONR FONAR | 9.7x | n/a | US$99.1m |
BDMD Baird Medical Investment Holdings | 1.6x | n/a | US$19.3m |
Price-To-Earnings vs Peers: BDMD is good value based on its Price-To-Earnings Ratio (1.6x) compared to the peer average (13.2x).
Price to Earnings Ratio vs Industry
How does BDMD's PE Ratio compare vs other companies in the US Medical Equipment Industry?
Price-To-Earnings vs Industry: BDMD is good value based on its Price-To-Earnings Ratio (1.6x) compared to the US Medical Equipment industry average (38.1x).
Price to Earnings Ratio vs Fair Ratio
What is BDMD's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 1.6x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate BDMD's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.